HomeNewsBusinessEconomyCentre releases Rs 75,000 crore to states as GST compensation shortfall

Centre releases Rs 75,000 crore to states as GST compensation shortfall

While these borrowings have been made by the centre, they will not count in its gross borrowing target of Rs 12.5 lakh crore for 2021-22 as the liability is being passed onto the states immediately.

July 15, 2021 / 20:02 IST
Story continues below Advertisement
Finance Minister Nirmala Sitharaman at a GST Council meet (Image: Twitter/@FinMinIndia)
Finance Minister Nirmala Sitharaman at a GST Council meet (Image: Twitter/@FinMinIndia)

The Finance Ministry, on July 15, said it has released Rs 75,000 crore to the states in lieu of Goods and Service Tax (GST) compensation shortfall.

The government said that almost 50 percent of the total shortfall for the entire year has been released in this single installment as a result, and the balance amount will be released in the second half of 2021-22 in steady installments.

The funds will be provided under the back-to-back loan facility for states first announced by the Centre last year. This latest release is in addition to normal GST compensation being released every two months out of actual cess collection, the government said.

Story continues below Advertisement

This arrangement was decided upon in the 43rd GST Council meet held on May 28 in the backdrop of the states being owed GST compensation of over Rs 2 lakh crore.

"This amount of Rs.1.59 lakh crore would be over and above the compensation in excess of Rs. 1 lakh crore(based on cess collection) that is estimated to be released to States/UTs with Legislature during this financial year," the Finance Ministry said on 15 July.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show